A Study of Aleglitazar in Type 2 Diabetes Patients With Moderate Renal Impairment

Clinical trial NCT01043029 · COMPLETED

Trial details

NCT number: NCT01043029
Sponsor: Hoffmann-La Roche
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Diabetes Mellitus Type 2

Start date: 2010-05-01
Primary completion: 2012-07-01
Enrollment: 302

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.